Paediatric medulloblastoma: Patterns of care and radiotherapy quality assurance in Australia

Australasian Radiology

Volumn 51, Issue 5, 2007, Pages 458-464

  Ahern, V ^a   Koh, E S ^a   Gebski, V ^a   Sathiyaseelan, Y ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

Medulloblastoma; Paediatrics; Quality assurance; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHILD; CHILD CARE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HEALTH CARE QUALITY; HUMAN; IMMOBILIZATION; MALE; MEDICAL DOCUMENTATION; MEDULLOBLASTOMA; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION SHIELD; SKULL IRRADIATION; SPINE;

ADOLESCENT; AUSTRALIA; CEREBELLAR NEOPLASMS; CHILD; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; PHYSICIAN'S PRACTICE PATTERNS; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34548381264     PISSN: 00048461     EISSN: 14401673     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2007.01753.x     Document Type: Article

References (27)

1. Taylor RE, Bailey CC, Robinson K et al. Results of a randomized study of preradiation chemotherapy versus RT alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study. J Clin Oncol 2002 21 : 1581 91.
2. Bernier V. Technical aspects in cerebrospinal irradiation. Pediatr Blood Cancer 2004 42 : 447 51.
3. Freeman CR, Taylor RE, Kortman R-D, Carrie C. RT for medulloblastoma in children: a perspective on current international clinical research efforts. Med Pediatr Oncol 2002 39 : 99 108.
4. Carrie C, Hoffstetter S, Gomez F et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Paediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 1999 45 : 435 9.
5. Mirabell R, Bleyer A, Huguenin P et al. Paediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 1997 37 : 523 9.
6. Halperin EC. Impact of radiation technique upon the outcome of treatment for medulloblastoma. Int J Radiat Oncol Biol Phys 1996 46 : 233 9.
7. Carrie C, Alapetite C, Mere P et al. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group. Radiother Oncol 1992 24 : 77 81.
8. Taylor RE, Bailey CC, Robinson KJ et al. Impact of RT parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys 2004 58 : 1184 93.
9. Back M, Ahern V, Berry M et al. Importance of radiation time and dose factors on outcome for childhood medulloblastoma. Australas Radiol 2005 49 : 298 303.
10. Packer RJ, Goldwein J, Nicholson HS et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol 1999 17 : 2127 36.
11. Mulhern RK, Palmer SL, Merchant TE et al. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 2005 23 : 5511 19.
12. Coles CE, Hoole ACF, Harden SV et al. Quantitative assessment of inter-clinician variability of target volume delineation for medulloblastoma: quality assurance for the SIOP PNET 4 trial protocol. Radiother Oncol 2003 69 : 189 94.
13. Soomal R, Mosleh-Shirazi MA, Saran F. Conventionally planned posterior fossa fields in medulloblastoma - a clinical audit (Abstract). In : 1st International Congress of Paediatric Radiation Oncology 18-20 Jun 2003, Lyon, France.
14. Olch AJ, Lavey RS. Dosimetric advantages on Intensity Modulated Radiation therapy compared to 3-D conformal or opposed lateral beams for the boost treatment of either surgical site or whole posterior fossa for medulloblastoma (Abstract). In : 1st International Congress of Paediatric Radiation Oncology 18-20 Jun 2003, Lyon, France.
15. Soomal R, Mosleh-Shirazi MA, Brada M. Cochlear avoidance in standard risk medulloblastoma: comparison of 3D conformal and IMRT planning techniques (Abstract). In : 1st International Congress of Paediatric Radiation Oncology 18-20 Jun 2003, Lyon, France.
16. Miralbell R, Fitzgerald TJ, Laurie F et al. Radiotherapy in pediatric medulloblastoma: quality assessment of Pediatric Oncology Group Trial 9031. Int J Radiat Oncol Biol Phys 2006 64 : 1325 30.
17. Tait DM, Thornton-Jones H, Bloom HJ et al. Adjuvant chemotherapy for medulloblastomas: the first multicentre controlled trial of the International Society of Paediatric Oncology (SIOP). Eur J Cancer 1990 26 : 464 9.
18. Evans AE, Jenkin RD, Sposto R et al. The treatment of medulloblastoma: results of a prospective randomised trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990 72 : 572 82.
19. Deutsch M, Thomas PRM, Krischer J et al. Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600 cGy/20) with reduced neuraxis irradiation (2,340 CGy/13) in patients with low stage medulloblastoma: a combined Children's Cancer Group-Pediatric Oncology Group Study. Pediatr Neurosurg 1996 24 : 167 77.
20. Kortmann RD, Kuhl J, Timmermann B et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT'91. Int J Radiat Oncol Biol Phys 2000 46 : 269 79.
21. Bailey CC, Gnekow A, Wellek S et al. Prospective randomised trial of chemotherapy given before RT in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995 25 : 166 78.
22. Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM. Intellectual outcome after reduced dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group Study. J Clin Oncol 2001 19 : 3470 76.
23. Mulhern RK, Kepner JL, Thomas PR, Armstrong D, Friedman HS, Kun LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Paediatric Oncology Group study. J Clin Oncol 1998 16 : 1723 8.
24. Paulino AC. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 2002 53 : 543 7.
25. Huang E, Teh BS, Strother DR et al. Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction in ototoxicity. Int J Radiat Oncol Biol Phys 2002 52 : 599 605.
26. Grill J, Sainte-Rose C, Jouvet A et al. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 2005 6 : 573 80.
27. Carrie C, Muracciole X, Gomez F et al. Conformal RT, reduced boost volume, hyperfractionated RT, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. Int J Radiat Oncol Biol Phys 2005 63 : 711 16.